Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations

Assessment of Disease Activity in Rheumatoid Arthritis with 18F-FDG PET

Catherine Beckers, Clio Ribbens, Béatrice André, Stefaan Marcelis, Olivier Kaye, Luc Mathy, Marie-Joëlle Kaiser, Roland Hustinx, Jacqueline Foidart and Michel G. Malaise
Journal of Nuclear Medicine June 2004, 45 (6) 956-964;
Catherine Beckers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clio Ribbens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Béatrice André
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefaan Marcelis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Kaye
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luc Mathy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Joëlle Kaiser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland Hustinx
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacqueline Foidart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel G. Malaise
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    18F-FDG PET images of healthy control subject (A and B) and RA patient with active disease (C and D). (A) 3D projection image of normal tracer distribution in knee. (B) Normal distribution in hand and wrist. (C) Rheumatoid knee. (D) Rheumatoid hand and wrist.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Percentage of PET positivity of different joints studied. *P < 0.05 compared with PET positivity (χ2 test). In ankles and MTP-1 joints, cohorts were too small to allow valid statistical analysis. S+ = swollen joints; T+ = tender joints; US+ = joints with synovial thickness ≥ 1 mm.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    SUVs (mean ± SD) in joints in which synovitis is observed (PET+) or not observed (PET−) by 18F-FDG PET analysis. *P < 0.05 compared with PET-positive joints.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    PET positivity (A) and SUVs (mean ± SD) (B) in different types of joints studied as joints were not swollen, not tender, and also US negative (0; n = 43) or were positive for 1 (n = 41), 2 (n = 110), or 3 (n = 162) parameters studied. *P < 0.05 compared with PET-positive joints.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Percentage of PET-positive joints according to synovial thickness measured by US.

Tables

  • Figures
    • View popup
    TABLE 1

    Comparison of PET Positivity According to Visual Analysis and Clinical or US Positivity

    Joints (n)Odd ratio* (95% CI)
    SwellingTendernessUS positivity
    All (356)4.8 (2.9–8)8.6 (4.8–15.6)11.7 (7–19.7)
    Knees (42)3.4 (0.8–13.4)4.6 (2.2–18.5)9.0 (1.8–45)
    Wrists† (25)10.0 (0.9–187)10.0 (0.9–187)10.0 (0.6–181)
    MCP (129)20 (4.5–89)57 (2.7–162)2.6 (1.7–3.4)
    PIP (128)5.1 (2.3–11.5)13.6 (4.7–40)22.5 (6.3–78)
    Ankles‡ (16)0.8 (0.3–2.1)NANA
    MTP-1§ (16)NANA6.1 (0.5–78)
    • ↵* Odd ratios in bold type are statistically significant.

    • ↵† Of 22 PET-positive wrists, 19 were swollen or tender and 20 were US positive.

    • ↵‡ Of 10 PET-positive ankles, 8 were swollen, 10 were tender, and 7 were US positive.

    • ↵§ Of 9 PET-positive MTP-1 joints, 9 were swollen, 7 were tender, and 8 were US positive.

    • NA = nonapplicable because of no value in some categories.

    • View popup
    TABLE 2

    Linear Correlations Between SUV and Synovial Thickness on US

    Joints (n)Location of US scanningrP
    All (356)0.56<0.0001
    Knees (42)Lateral patellar recess0.56<0.0001
    Suprapatellar recess0.78<0.0001
    Medial patellar recess0.73<0.0001
    Sum0.80<0.0001
    Wrists (25)Radiocarpal (top of lunate)0.440.02
    Intercarpal (top of capitate)0.400.04
    Sum0.500.01
    MCP (129)Dorsal surface0.50<0.0001
    PIP (128)Dorsal surface0.39<0.0001
    Ankles (16)Top of talar neck0.640.008
    MTP-1 (16)Dorsal surface0.360.2
    • Sum = combined thickness resulting from multiple scans (3 sites for knees and 2 sites for wrists).

    • P values ≤ 0.05 are significant.

    • View popup
    TABLE 3

    Individual Parameters of 13 Patients Who Had PET Studies of Knees, Wrists, and MCP and PIP Joints

    PatientParameters studied
    ClinicalBiologicUSComposite indices18F-FDG PET
    DD (y)S (n)T (n)PGA (mm)PhyGA (mm)MS (min)HAQESR (mm/h)*CRP (mg/L)US (n)†CST (mm)Doppler‡Doppler score§DAS28SDAIPET¶CSUV
    18142490881502.5053811766.19218.160.92361.9
    2713178279901.87335614.5357.250.51110.5
    37201587841801.2526221863.19237.258.31931.1
    43101163491201.62142339.9005.636.548.3
    57242496943002.5040351844.65158.375.52027.3
    61024245893152.1269291542.6008.273.02024.6
    718222288872401.2531602246.88167.871.52442.3
    818202193912402.2584411441.0008.569.51923.4
    99171792943002.7546971751.3257.767.31523.0
    1011285870601.621211710.5005.234.906.0
    111416209494902.251436930.33106.962.41426.1
    121212165871201.623655420.0007.567.71326.8
    1316171788841502.0054701861.3127.659.21626.9
    • ↵* Millimeters per first hour.

    • ↵† No. of joints with synovial thickness ≥1 mm measured by US.

    • ↵‡ No. of joints with at least 1 power Doppler signal.

    • ↵§ Sum of all scores attributed to all detected signals.

    • ↵¶ No. of joints where synovitis is observed on 18F-FDG PET analysis.

    • DD = disease duration; S = swollen joints; T = tender joints; MS = morning stiffness.

    • The clinical parameters swelling and tenderness, sonographic, and PET parameters were determined on the same 24 joints (knees, wrists, and MCP and PIP joints), whereas indices DAS28 and SDAI were calculated using a 28-joint count (the same 24, plus elbows and shoulders).

    • View popup
    TABLE 4

    Correlations Between PET Parameters and Other Parameters of Disease Activity in RA

    Parameters studiedNo. of PET-positive jointslog CSUV
    rPrP
    Clinical
        No. of swollen joints0.710.0070.580.04
        No. of tender joints0.860.00020.800.0009
        PGA0.600.030.580.04
        PhyGA0.730.0040.700.007
        Duration of morning stiffness0.450.10.400.2
        HAQ0.230.40.230.4
    Biologic
        log ESR0.680.010.560.049
        log CRP0.560.0490.720.006
    US
        No. of US-positive joints0.800.00090.710.006
        log cumulative synovial thickness0.88<0.00010.88<0.0001
        No. of Doppler-positive joints0.610.030.630.02
        Doppler score0.590.030.630.02
    Composite indices
        DAS280.90<0.00010.780.002
        SDAI0.90<0.00010.850.0002
    • P values ≤ 0.05 are significant.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 45 (6)
Journal of Nuclear Medicine
Vol. 45, Issue 6
June 1, 2004
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of Disease Activity in Rheumatoid Arthritis with 18F-FDG PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Assessment of Disease Activity in Rheumatoid Arthritis with 18F-FDG PET
Catherine Beckers, Clio Ribbens, Béatrice André, Stefaan Marcelis, Olivier Kaye, Luc Mathy, Marie-Joëlle Kaiser, Roland Hustinx, Jacqueline Foidart, Michel G. Malaise
Journal of Nuclear Medicine Jun 2004, 45 (6) 956-964;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Assessment of Disease Activity in Rheumatoid Arthritis with 18F-FDG PET
Catherine Beckers, Clio Ribbens, Béatrice André, Stefaan Marcelis, Olivier Kaye, Luc Mathy, Marie-Joëlle Kaiser, Roland Hustinx, Jacqueline Foidart, Michel G. Malaise
Journal of Nuclear Medicine Jun 2004, 45 (6) 956-964;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Oncologic Staging with 68Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than 18F-FDG PET/CT
  • Total-Body 18F-FDG PET/CT in Autoimmune Inflammatory Arthritis at Ultra-Low Dose: Initial Observations
  • Whole-Body Macrophage Positron Emission Tomography Imaging for Disease Activity Assessment in Early Rheumatoid Arthritis
  • Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET
  • A model of chronic enthesitis and new bone formation characterized by multimodal imaging
  • 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
  • In Vivo Imaging of Cell Proliferation Enables the Detection of the Extent of Experimental Rheumatoid Arthritis by 3'-Deoxy-3'-18F-Fluorothymidine and Small-Animal PET
  • 18F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study
  • Contrast-enhanced Coded Phase-inversion Harmonic Sonography of Knee Synovitis Correlates with Histological Vessel Density: 2 Automated Digital Quantifications
  • Inflammatory Cytokines and Hypoxia Contribute to 18F-FDG Uptake by Cells Involved in Pannus Formation in Rheumatoid Arthritis
  • Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis
  • Increased 18F-FDG Uptake in Degenerative Disease of the Spine: Characterization with 18F-FDG PET/CT
  • FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment
  • 18F-FDG PET in Rheumatoid Arthritis: There Still Is a Long Way to Go
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire